<CodeList xmlns="http://www.cdisc.org/ns/odm/v1.3" xmlns:nciodm="http://ncicb.nci.nih.gov/xml/odm/EVS/CDISC" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" OID="CL.C66738.TSPARMCD" Name="Trial Summary Parameter Test Code" DataType="text" nciodm:ExtCodeID="C66738" nciodm:CodeListExtensible="Yes">
                <Description>
                    <TranslatedText xml:lang="en">The test code for an individual characteristic of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial.</TranslatedText>
                </Description>
                <EnumeratedItem CodedValue="ACTSUB" nciodm:ExtCodeID="C98703">
                    <nciodm:CDISCSynonym>Actual Number of Subjects</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Actual number of subjects enrolled; may include subjects who were not randomized.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Actual Subject Number</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="ADAPT" nciodm:ExtCodeID="C98704">
                    <nciodm:CDISCSynonym>Adaptive Design</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Indicate if the study includes a prospectively planned opportunity for modification of one or more specified aspects of the study design and hypotheses based on analysis of data (usually interim data) from subjects in the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Adaptive Design</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="ADDON" nciodm:ExtCodeID="C49703">
                    <nciodm:CDISCSynonym>Added on to Existing Treatments</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Test Product Added to Existing Treatment</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="AGEMAX" nciodm:ExtCodeID="C49694">
                    <nciodm:CDISCSynonym>Planned Maximum Age of Subjects</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Planned Maximum Age of Subjects</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="AGEMIN" nciodm:ExtCodeID="C49693">
                    <nciodm:CDISCSynonym>Planned Minimum Age of Subjects</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Planned Minimum Age of Subjects</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="BIOSPRET" nciodm:ExtCodeID="C126058">
                    <nciodm:CDISCSynonym>Biospecimen Retention Contains DNA</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A textual description as to whether a biospecimen is retained and/or contains DNA.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Biospecimen Retained and/or Contains DNA Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="BLNDSTAT" nciodm:ExtCodeID="C139272">
                    <nciodm:CDISCSynonym>Blinded Status SDTM Dataset Generation</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Blinded Status at SDTM Dataset Generation</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The blinding status of the trial at the point in time when the SDTM datasets are generated.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Blinded Status at SDTM Dataset Generation</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="CITNSTDY" nciodm:ExtCodeID="C127788">
                    <nciodm:CDISCSynonym>Citation Used in Study</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A bibliographical reference related to a particular study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Clinical Study Citation</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="CMSPSTAT" nciodm:ExtCodeID="C127789">
                    <nciodm:CDISCSynonym>Commercial Sponsor Status</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The state or condition of the sponsor as pertains to whether the sponsor is considered a commercial entity.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Sponsor Commercial Status</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="COMPTRT" nciodm:ExtCodeID="C68612">
                    <nciodm:CDISCSynonym>Comparative Treatment Name</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A therapeutically active agent that is intended to provide reference measurements for the experimental protocol of a clinical trial.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Active Comparator Drug</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="CRMDUR" nciodm:ExtCodeID="C98715">
                    <nciodm:CDISCSynonym>Confirmed Response Minimum Duration</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The protocol specified minimum amount of time needed to meet the definition of a confirmed response to treatment.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Confirmed Response Minimum Duration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="CSRARDTC" nciodm:ExtCodeID="C139273">
                    <nciodm:CDISCSynonym>Clinical Study Report Archive Date</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The date when the clinical study report was archived.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Clinical Study Report Archive Date</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="CURTRT" nciodm:ExtCodeID="C85582">
                    <nciodm:CDISCSynonym>Current Therapy or Treatment</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The literal identifier of the therapy or medication that is currently being given per protocol.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Current Therapy</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DCUTDESC" nciodm:ExtCodeID="C98718">
                    <nciodm:CDISCSynonym>Data Cutoff Description</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Text that describes the cutoff date.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Data Cutoff Date Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DCUTDTC" nciodm:ExtCodeID="C98717">
                    <nciodm:CDISCSynonym>Data Cutoff Date</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A date which indicates any data collected by this date will be used for analysis.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Data Cutoff Date</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DGFCRIT" nciodm:ExtCodeID="C135514">
                    <nciodm:CDISCSynonym>Delayed Graft Function Diagnostic Criteria</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Delayed Graft Function Dx Criteria</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A standard by which the determination of delayed graft function (DGF) is established.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Delayed Graft Function Diagnostic Criteria Name</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DMCIND" nciodm:ExtCodeID="C127790">
                    <nciodm:CDISCSynonym>Data Monitoring Committee Indicator</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An indication as to whether the clinical trial has an appointed data monitoring committee.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Data Monitoring Committee Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DOSE" nciodm:ExtCodeID="C25488">
                    <nciodm:CDISCSynonym>Dose Level</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Dose per Administration</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Dose</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DOSFRQ" nciodm:ExtCodeID="C89081">
                    <nciodm:CDISCSynonym>Dosing Frequency</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The number of doses administered per a specific interval.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Dose Frequency</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DOSU" nciodm:ExtCodeID="C73558">
                    <nciodm:CDISCSynonym>Dose Units</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The unit of measure for the dosage form.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Dosage Form Unit</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="DXCRIT" nciodm:ExtCodeID="C117960">
                    <nciodm:CDISCSynonym>Diagnostic Criteria</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A standard from which a judgment concerning a medical diagnosis can be established.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Diagnostic Criteria</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="EGBLIND" nciodm:ExtCodeID="C119560">
                    <nciodm:CDISCSynonym>ECG Reading Blinded</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Indicates whether assessors of ECGs for this study were blinded to subject identity, timing and treatment.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>ECG Evaluator Blinding Parameters</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="EGCTMON" nciodm:ExtCodeID="C119561">
                    <nciodm:CDISCSynonym>ECG Continuous Monitoring</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Indicates whether the 10-second ECGs for this study were extracted from a continuous recording.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>ECG Continuous Monitoring Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="EGLEADPR" nciodm:ExtCodeID="C119562">
                    <nciodm:CDISCSynonym>ECG Planned Primary Lead</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The ECG lead which was planned to be used for ECG interval measurements for this study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>ECG Planned Primary Lead for Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="EGLEADSM" nciodm:ExtCodeID="C119563">
                    <nciodm:CDISCSynonym>ECG Used Same Lead</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Indicates whether all ECG interval measurements for the study were based on the same lead.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>ECG Used Same Lead Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="EGRDMETH" nciodm:ExtCodeID="C119564">
                    <nciodm:CDISCSynonym>ECG Read Method</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The degree of automation involved in assessing the ECGs for this study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>ECG Read Method Degree of Automation</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="EGREPLBL" nciodm:ExtCodeID="C119565">
                    <nciodm:CDISCSynonym>ECG Replicates at Baseline</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Indicates whether this study includes replicate ECGs for time points during the baseline portion of the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>ECG Replicates at Baseline Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="EGREPLTR" nciodm:ExtCodeID="C119566">
                    <nciodm:CDISCSynonym>ECG Replicates On-Treatment</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Indicates whether this study includes replicate ECGs for time points during the on-treatment portion of the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>ECG Replicates On-Treatment Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="EGTWVALG" nciodm:ExtCodeID="C119582">
                    <nciodm:CDISCSynonym>ECG Twave Algorithm</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The algorithm used to identify the end of the T wave for ECGs for this study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>ECG T Wave Algorithm</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="EMAILXML" nciodm:ExtCodeID="C127791">
                    <nciodm:CDISCSynonym>Email Address for XML File</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The Email address to which copies of the XML format of the EudraCT application should be sent.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>E-mail Address for XML File Feedback</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="EMPIPDCN" nciodm:ExtCodeID="C126059">
                    <nciodm:CDISCSynonym>EMA Decision Number for PIP</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An alphanumeric code assigned by the European Medicines Agency (EMA) to an EMA regulatory decision for a pediatric investigation plan (PIP).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>EMA Decision Number for Pediatric Investigation Plan</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="EURSBIND" nciodm:ExtCodeID="C126060">
                    <nciodm:CDISCSynonym>EudraCT Resubmission Indicator</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An indication as to whether the trial being submitted to the EudraCT is a trial that has been previously submitted to the EudraCT system.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>EudraCT Resubmission Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="EVSNDID" nciodm:ExtCodeID="C126061">
                    <nciodm:CDISCSynonym>EudraVigilance Sender ID</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A unique identifier assigned to the organization that is transmitting an adverse drug reaction report to the EudraVigilance system.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>EudraVigilance Sender Identifier</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="EVSNDORG" nciodm:ExtCodeID="C126090">
                    <nciodm:CDISCSynonym>EudraVigilance Sender Organization</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The name of the group or institution that is transmitting an adverse drug reaction report to the EudraVigilance system.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>EudraVigilance Sender Organization</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="EXPARECN" nciodm:ExtCodeID="C127792">
                    <nciodm:CDISCSynonym>Expanded Access Record NCT Number</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The unique alphanumeric identifier for the study with associated expanded access record, as assigned by the clinicaltrials.gov protocol registration and results system (PRS).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Clinicaltrials.gov NCT Number for the Expanded Access Record</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="EXPASTAT" nciodm:ExtCodeID="C127793">
                    <nciodm:CDISCSynonym>Expanded Access Status</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Status indicating availability of an experimental drug or device outside any clinical trial protocol. (clinicaltrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Trial Expanded Access Status</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="EXTTIND" nciodm:ExtCodeID="C139274">
                    <nciodm:CDISCSynonym>Extension Trial Indicator</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An indication as to whether the clinical trial is an extension trial.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Extension Trial Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="FCNTRY" nciodm:ExtCodeID="C98770">
                    <nciodm:CDISCSynonym>Planned Country of Investigational Sites</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The country name of planned study facility which has received IRB approval.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Planned Country of Investigational Site</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="FDADEIND" nciodm:ExtCodeID="C123629">
                    <nciodm:CDISCSynonym>FDA-Regulated Device Study Indicator</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An indication as to whether the study involves an FDA-regulated device.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>FDA-Regulated Device Study Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="FDADRIND" nciodm:ExtCodeID="C123630">
                    <nciodm:CDISCSynonym>FDA-Regulated Drug Study Indicator</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An indication as to whether the study involves an FDA-regulated drug.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>FDA-Regulated Drug Study Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="HLTSUBJI" nciodm:ExtCodeID="C98737">
                    <nciodm:CDISCSynonym>Healthy Subject Indicator</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Indicate if persons who have not had the condition(s) being studied or otherwise related conditions or symptoms, as specified in the eligibility requirements, may participate in the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Healthy Subject Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="INDIC" nciodm:ExtCodeID="C112038">
                    <nciodm:CDISCSynonym>Trial Disease/Condition Indication</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The condition, disease or disorder that the clinical trial is intended to investigate or address.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Trial Indication</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="INTMODEL" nciodm:ExtCodeID="C98746">
                    <nciodm:CDISCSynonym>Intervention Model</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The trial design developed to compare treatment groups.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Intervention Model</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="INTTYPE" nciodm:ExtCodeID="C98747">
                    <nciodm:CDISCSynonym>Intervention Type</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The kind of product or procedure studied in a trial.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Intervention Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="KEYWORD" nciodm:ExtCodeID="C126062">
                    <nciodm:CDISCSynonym>Protocol Keyword</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A word or small set of words designed to convey the focus of the protocol.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Protocol Keyword</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="LENGTH" nciodm:ExtCodeID="C49697">
                    <nciodm:CDISCSynonym>Trial Length</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Planned length of observation for a single subject.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Trial Length</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="MNFCNTRY" nciodm:ExtCodeID="C124455">
                    <nciodm:CDISCSynonym>Country of Manufacture</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The name of the country within which the final product under study is produced.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Country of Manufacture</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="MSEUTIND" nciodm:ExtCodeID="C127794">
                    <nciodm:CDISCSynonym>Multiple Site EU State Trial Indicator</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An indication as to whether the clinical study is being conducted at multiple sites within the European Union member state concerned by the application.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Multiple Site European Union State Trial Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="NARMS" nciodm:ExtCodeID="C98771">
                    <nciodm:CDISCSynonym>Planned Number of Arms</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The planned number of intervention groups.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Planned Number of Arms</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="NCOHORT" nciodm:ExtCodeID="C126063">
                    <nciodm:CDISCSynonym>Number of Groups/Cohorts</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The number of groups or cohorts that are part of the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Number of Groups or Cohorts</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="NUMSEUST" nciodm:ExtCodeID="C127795">
                    <nciodm:CDISCSynonym>Number of Trial Sites EU State</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The total number of trial sites within the European Union member state concerned by the application.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Number of Trial Sites within European Union State</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="OBJPRIM" nciodm:ExtCodeID="C85826">
                    <nciodm:CDISCSynonym>Trial Primary Objective</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The principal purpose of the trial.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Trial Primary Objective</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="OBJSEC" nciodm:ExtCodeID="C85827">
                    <nciodm:CDISCSynonym>Trial Secondary Objective</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The auxiliary purpose of the trial.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Trial Secondary Objective</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="OBSMODEL" nciodm:ExtCodeID="C126064">
                    <nciodm:CDISCSynonym>Observational Model</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The trial design developed to compare biomedical and/or health outcomes in pre-defined and non-assigned groups of individuals.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Observational Model</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="OBSTIMP" nciodm:ExtCodeID="C126065">
                    <nciodm:CDISCSynonym>Observational Time Perspective</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The temporal relationship between the observation period and time of subject enrollment. (ClinicalTrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Observational Time Perspective of Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="OBSTPOPD" nciodm:ExtCodeID="C126066">
                    <nciodm:CDISCSynonym>Obs Study Population Description</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A description of the population from which the groups or cohorts will be selected within an observational study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Observational Study Population Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="OBSTSMM" nciodm:ExtCodeID="C126067">
                    <nciodm:CDISCSynonym>Observational Study Sampling Method</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The sampling method used to assign study participants into groups or cohorts within an observational study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Observational Study Sampling Method</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="OBSTSMMD" nciodm:ExtCodeID="C126068">
                    <nciodm:CDISCSynonym>Obs Study Sampling Method Description</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A textual description of the sampling method used to assign study participants into groups or cohorts within an observational study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Observational Study Sampling Method Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="OUTMSEXP" nciodm:ExtCodeID="C98724">
                    <nciodm:CDISCSynonym>Exploratory Outcome Measure</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Exploratory measures that will be used to evaluate the intervention(s) or, for observational studies, that are exploratory of the study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Exploratory Outcome Measure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="OUTMSPRI" nciodm:ExtCodeID="C98772">
                    <nciodm:CDISCSynonym>Primary Outcome Measure</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The primary measurement(s) or observation(s) used to measure the effect of experimental variables in a study, or for observational studies, to describe patterns of diseases or traits or associations with exposures, risk factors or treatment. These are the outcome measures used to assess the primary objective(s).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Primary Outcome Measure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="OUTMSSEC" nciodm:ExtCodeID="C98781">
                    <nciodm:CDISCSynonym>Secondary Outcome Measure</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Other key measures that will be used to evaluate the intervention(s) or, for observational studies, that are a focus of the study. These are the outcome measures used to assess the secondary objective(s).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Secondary Outcome Measure</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PASSIND" nciodm:ExtCodeID="C139275">
                    <nciodm:CDISCSynonym>Post Authorization Safety Study Ind</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An indication as to whether the clinical study is a post authorization safety study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Post Authorization Safety Study Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PCLAS" nciodm:ExtCodeID="C98768">
                    <nciodm:CDISCSynonym>Pharmacologic Class</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The pharmacological class of the investigational product.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Pharmacological Class of Investigational Therapy</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PDPSTIND" nciodm:ExtCodeID="C123631">
                    <nciodm:CDISCSynonym>Pediatric Postmarket Study Indicator</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An indication as to whether the study is a pediatric postmarket study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Pediatric Postmarket Study Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PDSTIND" nciodm:ExtCodeID="C123632">
                    <nciodm:CDISCSynonym>Pediatric Study Indicator</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An indication as to whether the study is a pediatric study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Pediatric Study Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PIPIND" nciodm:ExtCodeID="C126069">
                    <nciodm:CDISCSynonym>Pediatric Investigation Plan Indicator</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An indication as to whether the trial is part of a pediatric investigation plan (PIP).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Pediatric Investigation Plan Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PLANSUB" nciodm:ExtCodeID="C49692">
                    <nciodm:CDISCSynonym>Anticipated Enrollment</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Planned Enrollment</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Planned Number of Subjects</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Target Enrollment</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The planned number of subjects to be entered in a clinical trial. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Planned Subject Number</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PLNTRDUR" nciodm:ExtCodeID="C127796">
                    <nciodm:CDISCSynonym>Planned Trial Duration</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The approximate period of time over which the clinical trial is expected to occur.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Planned Trial Duration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PROTRSK" nciodm:ExtCodeID="C139277">
                    <nciodm:CDISCSynonym>Protocol Risk Assessment</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The potential future harm that may arise from a protocol-related activity.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Protocol Risk Assessment</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PTRTDUR" nciodm:ExtCodeID="C139276">
                    <nciodm:CDISCSynonym>Planned Treatment Duration</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The period of time during which the treatment is intended to be given.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Planned Treatment Duration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="PUBMEDID" nciodm:ExtCodeID="C127797">
                    <nciodm:CDISCSynonym>PubMed ID for Citation Used in Study</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A globally unique identifier for a biomedical article, as assigned by PubMed.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>PubMed Identifier for Citation Used in Study</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="RANDOM" nciodm:ExtCodeID="C25196">
                    <nciodm:CDISCSynonym>Trial is Randomized</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Randomization</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="RANDQT" nciodm:ExtCodeID="C98775">
                    <nciodm:CDISCSynonym>Randomization Quotient</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The randomization quotient is the number of planned subjects to be exposed to investigational therapy, independent of dose or other factors, divided by the total number of planned subjects.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Randomization Quotient</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="RDIND" nciodm:ExtCodeID="C126070">
                    <nciodm:CDISCSynonym>Rare Disease Indicator</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An indication as to whether the condition under study is considered a rare disease.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Rare Disease Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="REGID" nciodm:ExtCodeID="C98714">
                    <nciodm:CDISCSynonym>Registry Identifier</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Identification numbers assigned to the protocol by clinicaltrials.gov, EudraCT, or other registries.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Clinical Trial Registry Identifier</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="RESUBLTR" nciodm:ExtCodeID="C126071">
                    <nciodm:CDISCSynonym>Resubmission Letter</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An alphabetic character that describes the incremental order of trial resubmissions.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Resubmission Letter</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="RLPSCRIT" nciodm:ExtCodeID="C117961">
                    <nciodm:CDISCSynonym>Relapse Criteria</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A standard from which a judgment concerning a disease relapse can be established.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Relapse Criteria</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="ROUTE" nciodm:ExtCodeID="C38114">
                    <nciodm:CDISCSynonym>Route of Administration</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The course by which a substance is administered in order to reach the site of action in the body.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Route of Administration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="RTSPCDES" nciodm:ExtCodeID="C126072">
                    <nciodm:CDISCSynonym>Retained Biospecimen Description</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A textual description of the specimen types that are retained as reserve samples.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Retained Biospecimen Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="RXMLCIND" nciodm:ExtCodeID="C127798">
                    <nciodm:CDISCSynonym>Request for XML Copy of Study Indicator</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An indication as to whether the registrant would like to receive an XML copy of their study as saved on EudraCT.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Saved as XML Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SDMDUR" nciodm:ExtCodeID="C98783">
                    <nciodm:CDISCSynonym>Stable Disease Minimum Duration</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The protocol specified minimum amount of time needed to meet the definition of stable disease.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Stable Disease Minimum Duration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SDXMLIND" nciodm:ExtCodeID="C127799">
                    <nciodm:CDISCSynonym>Secure Delivery XML Required Indicator</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An indication as to whether the XML copy of the EudraCT application requires secure E-mail delivery.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Requires Secure Email Delivery of XML Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SENDTC" nciodm:ExtCodeID="C90462">
                    <nciodm:CDISCSynonym>Study End Date</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Final date on which data was collected for any subject (Date/Time of End of Participation, RFPENDTC) based on the protocol.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study End Date</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SEVCRIT" nciodm:ExtCodeID="C117962">
                    <nciodm:CDISCSynonym>Severity Criteria</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A standard from which a judgment concerning the severity of an event, disease or condition can be established.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Severity Criteria</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SEXPOP" nciodm:ExtCodeID="C49696">
                    <nciodm:CDISCSynonym>Sex of Participants</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The specific sex, either male, female, or mixed of the subject group being studied. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Sex of Study Group</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SPONSOR" nciodm:ExtCodeID="C70793">
                    <nciodm:CDISCSynonym>Clinical Study Sponsor</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Sponsor</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Study Sponsor</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An entity that is responsible for the initiation, management, and/or financing of a clinical study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Clinical Study Sponsor</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SREVIND" nciodm:ExtCodeID="C126073">
                    <nciodm:CDISCSynonym>SUSAR Reporting to EVCTM Indicator</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An indication as to whether suspected unexpected serious adverse reactions (SUSAR) will be reported to a EudraVigiliance clinical trial module (EVCTM).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>SUSAR Reporting to EudraVigiliance Clinical Trial Module Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SRNCAIND" nciodm:ExtCodeID="C126074">
                    <nciodm:CDISCSynonym>SUSAR Reporting to NCA Indicator</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An indication as to whether suspected unexpected serious adverse reactions (SUSAR) will be reported to national competent authorities (NCA).</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>SUSAR Reporting to National Competent Authority Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SSEUTIND" nciodm:ExtCodeID="C127800">
                    <nciodm:CDISCSynonym>Single Site EU State Trial Indicator</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An indication as to whether the clinical study is being conducted at only one site within the European Union member state concerned by the application.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Single Site European Union State Trial Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SSTDTC" nciodm:ExtCodeID="C69208">
                    <nciodm:CDISCSynonym>Study Start Date</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The earliest date of informed consent among any subject (Date/Time of Informed Consent, RFICDTC) that enrolled in the study. For studies conducted without informed consent (ie. emergency use) use the date of treatment. Dates for subjects who were screen failures are not included.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Start Date</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SSTDYDTL" nciodm:ExtCodeID="C126075">
                    <nciodm:CDISCSynonym>Substudy Details</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A textual description of the substudy.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Substudy Details</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="SSTDYIND" nciodm:ExtCodeID="C126076">
                    <nciodm:CDISCSynonym>Substudy Planned Indicator</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>An indication as to whether a study performed on a subgroup of subjects included in the original trial (substudy) is planned for the current study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Substudy Planned Indicator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="STOPRULE" nciodm:ExtCodeID="C49698">
                    <nciodm:CDISCSynonym>Study Stop Rules</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Stop Rule</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="STRATFCT" nciodm:ExtCodeID="C16153">
                    <nciodm:CDISCSynonym>Stratification Factor</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Selected pre-treatment factors by which patients are segregated to assure balance of these factors before randomization to the intervention arms of a clinical protocol.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Stratification Factors</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="STYPE" nciodm:ExtCodeID="C142175">
                    <nciodm:CDISCSynonym>Study Type</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Describes the role the study plays in determining the interventions a subject receives.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="TBLIND" nciodm:ExtCodeID="C49658">
                    <nciodm:CDISCSynonym>Trial Blinding Schema</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The type of experimental design used to describe the level of awareness of the clinical trial subjects and/or investigators of the intervention(s) that they are receiving and/or administering.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Trial Blinding Schema</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="TCNTRL" nciodm:ExtCodeID="C49647">
                    <nciodm:CDISCSynonym>Control Type</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Comparator against which the study treatment is evaluated.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Control Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="TDIGRP" nciodm:ExtCodeID="C49650">
                    <nciodm:CDISCSynonym>Diagnosis Group</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A grouping of individuals on the basis of a shared procedure or disease, or lack thereof.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Diagnosis Group</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="THERAREA" nciodm:ExtCodeID="C101302">
                    <nciodm:CDISCSynonym>Therapeutic Area</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A knowledge field that focuses on research and development of specific treatments for diseases and pathologic findings, as well as prevention of conditions that negatively impact the health of an individual. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Therapeutic Area</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="TINDTP" nciodm:ExtCodeID="C49652">
                    <nciodm:CDISCSynonym>Trial Intent Type</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The planned purpose of the therapy, device, or agent under study in the clinical trial.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Clinical Study by Intent</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="TITLE" nciodm:ExtCodeID="C49802">
                    <nciodm:CDISCSynonym>Trial Title</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The name of a clinical trial. (NCI)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Trial Title</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="TPHASE" nciodm:ExtCodeID="C48281">
                    <nciodm:CDISCSynonym>Trial Phase Classification</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>Any defined stage in the lifecycle of a clinical trial.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Trial Phase</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="TRGFUDUR" nciodm:ExtCodeID="C126077">
                    <nciodm:CDISCSynonym>Target Follow-Up Duration</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The anticipated time period over which each study participant is to be followed. (ClinicalTrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Planned Follow-Up Duration</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="TRT" nciodm:ExtCodeID="C41161">
                    <nciodm:CDISCSynonym>Investigational Therapy or Treatment</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The investigational product under study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Protocol Agent</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="TTYPE" nciodm:ExtCodeID="C49660">
                    <nciodm:CDISCSynonym>Trial Scope</nciodm:CDISCSynonym>
                    <nciodm:CDISCSynonym>Trial Type</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The type of primary outcome or endpoint that the protocol is designed to evaluate. (clinicaltrials.gov)</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Trial Type</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="URLSTDY" nciodm:ExtCodeID="C127801">
                    <nciodm:CDISCSynonym>URL Related to Study</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>The uniform resource locator (URL) related to a particular study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Protocol Uniform Resource Locator</nciodm:PreferredTerm>
                </EnumeratedItem>
                <EnumeratedItem CodedValue="URLSTDYD" nciodm:ExtCodeID="C127802">
                    <nciodm:CDISCSynonym>URL Related to Study Description</nciodm:CDISCSynonym>
                    <nciodm:CDISCDefinition>A textual description of the uniform resource locator (URL) related to a particular study.</nciodm:CDISCDefinition>
                    <nciodm:PreferredTerm>Study Protocol Uniform Resource Locator Description</nciodm:PreferredTerm>
                </EnumeratedItem>
                <nciodm:CDISCSubmissionValue>TSPARMCD</nciodm:CDISCSubmissionValue>
                <nciodm:CDISCSynonym>Trial Summary Parameter Test Code</nciodm:CDISCSynonym>
                <nciodm:PreferredTerm>CDISC SDTM Trial Summary Parameter Short Name Terminology</nciodm:PreferredTerm>
            </CodeList>
            
